Thanks for visiting Research Information.

You're trying to access an editorial feature that is only available to logged in, registered users of Research Information. Registering is completely free, so why not sign up with us?

By registering, as well as being able to browse all content on the site without further interruption, you'll also have the option to receive our magazine (multiple times a year) and our email newsletters.

Wolters Kluwer sells healthcare analytics business

Share this on social media:

​Wolters Kluwer has sold its pharma-related Healthcare Analytics business to private equity firm Symphony Technology Group (STG). 

Healthcare Analytics provides patient and physician-level prescription and usage data to the pharmaceutical industry. STG's portfolio companies capture high value data around physicians' treatment decisions in response to pharmaceutical promotion.

The sale of the pharma-related business is said to be part of Wolter Kluwer's strategy to focus on its core health markets and providing 'innovative solutions to clinicians'. In July 2011 the company announced plans to divest its pharma-related assests.

'After conducting a thorough process, the sale to STG is a perfect fit for Healthcare Analytics, its customers and employees,' commented Bob Becker, CEO and president of Wolters Kluwer Health. 'STG and its portfolio companies bring deep expertise in technology and analytics as well as a strong commitment to the pharmaceutical industry.'